Management of chronic obstructive pulmonary disease: the Swiss Guidelines
暂无分享,去创建一个
T. Rochat | T. Rochat | E. Russi | O. Brändli | R. Schibli | M. Pons | M. Gugger | W. Karrer | E. Grebski | J. Frey | P. Leuenberger | A. Paky | M. Kuhn | M. Soler | J. Wacker | Michael Kuhn | JG Frey
[1] A. Buist. Guidelines for the management of chronic obstructive pulmonary disease. , 2002, Respiratory medicine.
[2] F. Ram,et al. Short-acting beta2-agonists for stable chronic obstructive pulmonary disease , 2002 .
[3] E. Russi,et al. Improved quality of life after lung volume reduction surgery , 2002, European Respiratory Journal.
[4] R. Dahl,et al. Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[5] M. Elliott,et al. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome , 2001, Thorax.
[6] A. Nissinen,et al. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study , 2001, Thorax.
[7] F. Platt,et al. Let Me See If I Have This Right : Words That Help Build Empathy , 2001, Annals of Internal Medicine.
[8] C. Brambilla,et al. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study , 2001, The Lancet.
[9] D. Mahler,et al. Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD. , 2001, The European respiratory journal.
[10] A. Cuvelier,et al. Noninvasive ventilation and obstructive lung diseases. , 2001, The European respiratory journal.
[11] N. Zamel,et al. Lung function 5 yr after lung volume reduction surgery for emphysema. , 2001, American journal of respiratory and critical care medicine.
[12] R. Zuwallack,et al. Salmeterol plus theophylline combination therapy in the treatment of COPD. , 2001, Chest.
[13] N. Ambrosino,et al. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. , 2001, Chest.
[14] J. Finnerty,et al. The effectiveness of outpatient pulmonary rehabilitation in chronic lung disease: a randomized controlled trial. , 2001, Chest.
[15] P. Poole,et al. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review , 2001, BMJ : British Medical Journal.
[16] P. Anderson,et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial , 2001, The Lancet.
[17] M. De Salvo,et al. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study. , 2001, Chest.
[18] V. Snow,et al. Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.
[19] D. Mccrory,et al. Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.
[20] R. Zuwallack,et al. Use of a Long-acting Inhaled β2-Adrenergic Agonist, Salmeterol Xinafoate, in Patients with Chronic Obstructive Pulmonary Disease , 2001 .
[21] R. Pauwels,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.
[22] D. Mccrory,et al. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. , 2001, Chest.
[23] M. Saetta,et al. Pathogenesis and Pathology of COPD , 2001, Respiration.
[24] N. Konietzko,et al. Longitudinal Follow-up of Patients With α1-Protease Inhibitor Deficiency Before and During Therapy With IV α1-Protease Inhibitor , 2001 .
[25] M. Decramer,et al. The Bronchitis Randomized On NAC Cost-Utility Study (BRONCUS): hypothesis and design. BRONCUS-trial Committee. , 2001, The European respiratory journal.
[26] D. Brooks,et al. Nutritional intervention in COPD: a systematic overview. , 2001, Chest.
[27] N. Konietzko,et al. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. , 2001, Chest.
[28] R. Zuwallack,et al. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[29] J. Connett,et al. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.
[30] H. Schäfers,et al. Lung volume reduction surgery versus conservative treatment in severe emphysema. , 2000, The European respiratory journal.
[31] Robert West,et al. Smoking cessation guidelines for health professionals: an update , 2000, Thorax.
[32] J. Lieberman. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data. , 2000, Chest.
[33] T. Mineo,et al. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. , 2000, The Annals of thoracic surgery.
[34] J. Steurer,et al. The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. , 2000, The European respiratory journal.
[35] D. Hansell,et al. Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.
[36] E. Wouters,et al. Characterization of Nonresponse to High Caloric Oral Nutritional Therapy in Depleted Patients With Chronic Obstructive Pulmonary Disease , 2000 .
[37] M. Niederman,et al. The role of bacteria in exacerbations of COPD. A constructive view. , 2000, Chest.
[38] M. Elliott,et al. One year period prevalence study of respiratory acidosis in acute exacerbations of COPD: implications for the provision of non-invasive ventilation and oxygen administration , 2000, Thorax.
[39] T L Petty,et al. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. , 2000, Archives of internal medicine.
[40] S. Spencer,et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.
[41] W. Hop,et al. Long-term treatment of chronic obstructive pulmonary disease with salmeterol and the additive effect of ipratropium. , 2000, The European respiratory journal.
[42] A. Buist,et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. , 2000, Chest.
[43] M. Littner,et al. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[44] J. V. van Noord,et al. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease , 2000 .
[45] P. O'Malley,et al. Should Health-Care Systems Pay for Replacement Therapy in Patients With α1-Antitrypsin Deficiency? , 2000 .
[46] N. Hill. Noninvasive ventilation has been shown to be ineffective in stable COPD. , 2000, American journal of respiratory and critical care medicine.
[47] A. Rossi. Noninvasive ventilation has not been shown to be ineffective in stable COPD. , 2000, American journal of respiratory and critical care medicine.
[48] D. Brooks,et al. Nutritional support for individuals with COPD: a meta-analysis. , 2000, Chest.
[49] Barnes Pj. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. , 2000 .
[50] D. Mahler. How should health-related quality of life be assessed in patients with COPD? , 2000, Chest.
[51] S. Hurd,et al. The impact of COPD on lung health worldwide: epidemiology and incidence. , 2000, Chest.
[52] N. Payne,et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.
[53] P. O'Malley,et al. Should health-care systems pay for replacement therapy in patients with alpha(1)-antitrypsin deficiency? A critical review and cost-effectiveness analysis. , 2000, Chest.
[54] F. Ram,et al. Short-acting beta 2 agonists for stable COPD. , 2000, The Cochrane database of systematic reviews.
[55] P. Barnes. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[56] M. Schluchter,et al. Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. , 2000, American journal of respiratory and critical care medicine.
[57] B. Smith,et al. Long-acting beta2-agonists for chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.
[58] A. Cripps,et al. Haemophilus influenzae oral vaccination against acute bronchitis. , 2000, The Cochrane database of systematic reviews.
[59] T. Lasserson,et al. Lung volume reduction surgery for diffuse emphysema. , 2000, The Cochrane database of systematic reviews.
[60] M. Schluchter,et al. Feasibility of a Clinical Trial of Augmentation Therapy for α1-Antitrypsin Deficiency , 2000 .
[61] G. Criner,et al. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[62] J. Vestbo,et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[63] E. Russi,et al. Two years' outcome of lung volume reduction surgery in different morphologic emphysema types. , 1999, The Annals of thoracic surgery.
[64] H A Vrooman,et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.
[65] J. Vestbo,et al. Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. , 1999, Respiratory medicine.
[66] A. Adelman. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. , 1999, The Journal of family practice.
[67] L. Davies,et al. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.
[68] E. Russi,et al. Functional and morphological heterogeneity of emphysema and its implication for selection of patients for lung volume reduction surgery. , 1999, The European respiratory journal.
[69] L. Davies,et al. Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease. , 1999, QJM : monthly journal of the Association of Physicians.
[70] P. Jones,et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease , 1999, Thorax.
[71] D. Postma,et al. Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .
[72] D. Niewoehner,et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.
[73] P. Lange,et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.
[74] C. Westermann,et al. Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. , 1999, The European respiratory journal.
[75] U Ackermann-Liebrich,et al. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. , 1999, American journal of respiratory and critical care medicine.
[76] Y. Lacasse,et al. Overviews of respiratory rehabilitation in chronic obstructive pulmonary disease. , 1999, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[77] S. Yancey,et al. Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.
[78] Aker,et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.
[79] D. Mannino,et al. Worldwide epidemiology of chronic obstructive pulmonary disease. , 1999, Current opinion in pulmonary medicine.
[80] R. Wilson. Bacterial infection and chronic obstructive pulmonary disease. , 1999, European Respiratory Journal.
[81] M. Moy,et al. Health-related quality of life improves following pulmonary rehabilitation and lung volume reduction surgery. , 1999, Chest.
[82] S. Campbell,et al. For COPD a combination of ipratropium bromide and albuterol sulfate is more effective than albuterol base. , 1999, Archives of internal medicine.
[83] D. Postma,et al. Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis , 1999, Thorax.
[84] G. Criner,et al. Improvements in lung function, exercise, and quality of life in hypercapnic COPD patients after lung volume reduction surgery. , 1999, Chest.
[85] D. Brooks,et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. , 1998, Chest.
[86] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[87] W. Stalman,et al. Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, The Netherlands. , 1998, Journal of epidemiology and community health.
[88] J Zieliński,et al. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. , 1998, Chest.
[89] J. Collet,et al. Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. , 1997, American journal of respiratory and critical care medicine.
[90] C. Pichard,et al. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. , 1997, American journal of respiratory and critical care medicine.
[91] Alison E. Ries. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based guidelines. ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel. American College of Chest Physicians. American Association of Cardiovascular and Pulmonary Rehabilitation. , 1997, Chest.
[92] Darrell R. Schroeder,et al. A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation , 1997 .
[93] N. Banik,et al. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. , 1997, The European respiratory journal.
[94] D. Mannino,et al. Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. , 1997, American journal of respiratory and critical care medicine.
[95] J. M. FitzGerald,et al. Bronchodilator delivery in acute airflow obstruction. A meta-analysis. , 1997, Archives of internal medicine.
[96] R. Zuwallack,et al. Body composition and health-related quality of life in patients with obstructive airways disease. , 1997, The European respiratory journal.
[97] J. Stoller. Clinical features and natural history of severe α1-antitrypsin deficiency , 1997 .
[98] T. Sensky,et al. Psychosocial predictors of long-term success of in-patient pulmonary rehabilitation of patients with COPD. , 1997, The European respiratory journal.
[99] T. Rochat,et al. Management 1997 of chronic obstructive pulmonary disease. Working Group of the Swiss Society of Pneumology. , 1997, Schweizerische medizinische Wochenschrift.
[100] R. Breiman,et al. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .
[101] A. Morice,et al. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.
[102] P. Jones,et al. Quality of life changes in COPD patients treated with salmeterol. , 1997, American journal of respiratory and critical care medicine.
[103] J. Heffner,et al. Outcomes of advance directive education of pulmonary rehabilitation patients. , 1997, American journal of respiratory and critical care medicine.
[104] P. Barnes,et al. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.
[105] J. Stoller. Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture. , 1997, Chest.
[106] D. Schroeder,et al. A comparison of sustained-release bupropion and placebo for smoking cessation. , 1997, The New England journal of medicine.
[107] [Guidelines for long-term home oxygen therapy in patients with chronic respiratory insufficiency. Swiss Society for Tuberculosis and Lung Diseases Control and Swiss Society of Pneumology]. , 1997, Schweizerische medizinische Wochenschrift.
[108] J. P. Davis,et al. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[109] Alan D. Lopez,et al. Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.
[110] Gordon H Guyatt,et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.
[111] J. Crowley,et al. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. , 1996, American journal of respiratory and critical care medicine.
[112] S. Rennard,et al. Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. , 1996, Chest.
[113] M. Decramer,et al. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[114] E. Silverman,et al. Risk factors for the development of chronic obstructive pulmonary disease. , 1996, The Medical clinics of North America.
[115] D. Postma,et al. Effects of long-term treatment with corticosteroids in COPD. , 1996, Chest.
[116] M. Decramer,et al. Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.
[117] D. Maldonado,et al. Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.
[118] J. Henningfield. Nicotine medications for smoking cessation. , 1995, The New England journal of medicine.
[119] J. Deslauriers,et al. Indications for surgery and patient work-up for bullectomy. , 1995, Chest surgery clinics of North America.
[120] E. Wouters,et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.
[121] B. Celli,et al. Long-term oxygen therapy. , 1995, The New England journal of medicine.
[122] J C Yernault,et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. , 1995, The European respiratory journal.
[123] M. Stewart. Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[124] P. Barnes,et al. Theophylline and phosphodiesterase inhibitors. , 1995, The European respiratory journal.
[125] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[126] J. Cooper,et al. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.
[127] W. Bailey,et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. , 1995, JAMA.
[128] U. Ackermann-Liebrich,et al. Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.
[129] A. Buist,et al. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone: An 85-day multicenter trial , 1994 .
[130] K. Nichol,et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. , 1994, The New England journal of medicine.
[131] P. Hawkey,et al. Antibiotics in chronic obstructive pulmonary disease , 1994, BMJ.
[132] B. Delclaux,et al. Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis. , 1994, The European respiratory journal.
[133] D. Mant,et al. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.
[134] O. Brändli,et al. [High-caloric nutrition in chronic obstructive lung disease]. , 1994, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis.
[135] S. Rennard,et al. Recommendations for guidelines on clinical trials of mucoactive drugs in chronic bronchitis and chronic obstructive pulmonary disease. Task Group on Mucoactive Drugs. , 1994, Chest.
[136] A. Buist,et al. The Lung Health Study. Baseline characteristics of randomized participants. , 1993, Chest.
[137] B. Griffith,et al. Lung transplantation: Report of the ATS workshop on lung transplantation , 1993 .
[138] D. Postma,et al. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. , 1992, The European respiratory journal.
[139] H Spiro,et al. What is empathy and can it be taught? , 1992, Annals of internal medicine.
[140] J. Fitting. Nutritional support in chronic obstructive lung disease. , 1992, Thorax.
[141] J. Samet,et al. Epidemiologic approaches for assessing health risks from complex mixtures in indoor air. , 1991, Environmental health perspectives.
[142] P. Howard,et al. Oral almitrine in treatment of acute respiratory failure and cor pulmonale in patients with an exacerbation of chronic obstructive airways disease. , 1991, Thorax.
[143] B. Burrows. Epidemiologic evidence for different types of chronic airflow obstruction. , 1991, The American review of respiratory disease.
[144] D. Clemmons,et al. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. , 1991, Chest.
[145] G. Patterson,et al. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group. , 1991, The Journal of thoracic and cardiovascular surgery.
[146] N. Pride,et al. A "splitting" look at chronic nonspecific lung disease (CNSLD): common features but diverse pathogenesis. , 1991, The European respiratory journal.
[147] R. Dittus,et al. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis. , 1991, Annals of internal medicine.
[148] V. Kvetan,et al. Growth hormone and pulmonary disease. Metabolic effects in patients receiving parenteral nutrition. , 1990, Archives of internal medicine.
[149] T. Sensky,et al. Patients' reactions to illness. , 1990, BMJ.
[150] M. Becklake. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.
[151] T. Thom. International comparisons in COPD mortality. , 1989, The American review of respiratory disease.
[152] O. Brändli,et al. [Course and prognosis of chronic obstructive lung disease over 5 and 10 years]. , 1988, Schweizerische medizinische Wochenschrift.
[153] D. Postma,et al. Moderately severe chronic airflow obstruction. Can corticosteroids slow down obstruction? , 1988, The European respiratory journal.
[154] N. Anthonisen,et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.
[155] N. Anthonisen,et al. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. , 1986, The New England journal of medicine.
[156] D. Postma,et al. Severe chronic airflow obstruction: can corticosteroids slow down progression? , 1985, European journal of respiratory diseases.
[157] C. Wells,et al. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.
[158] Cotes Je,et al. LONG TERM DOMICILIARY OXYGEN THERAPY IN CHRONIC HYPOXIC COR PULMONALE COMPLICATING CHRONIC BRONCHITIS AND EMPHYSEMA Report of the Medical Research Council Working Party , 1981, The Lancet.
[159] Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. , 1980, Annals of internal medicine.
[160] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[161] I. Grant. Chronic Airflow Obstruction in Lung Disease , 1977 .
[162] D. Smith,et al. Five-year winter chemoprophylaxis for chronic bronchitis , 1969, British medical journal.